Amundi Asset Management US’s CVS Health CVS Stock Holding History

Amundi Asset Management US’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$238M	Buy	3,159,089 +497,151	+19%	+$36.2M	0.18%	123
2020 Q4	$182M	Buy	2,661,938 +446,254	+20%	+$29M	0.15%	153
2020 Q3	$129M	Buy	2,215,684 +54,628	+3%	+$3.4M	0.14%	153
2020 Q2	$140M	Buy	2,161,056 +477,791	+28%	+$30.1M	0.17%	122
2020 Q1	$99.9M	Sell	1,683,265 -605,505	-26%	-$40.4M	0.17%	111
2019 Q4	$170M	Buy	2,288,770 +592,954	+35%	+$41.6M	0.2%	117
2019 Q3	$107M	Buy	1,695,816 +375,881	+28%	+$22.3M	0.16%	153
2019 Q2	$71.9M	Sell	1,319,935 -26,220	-2%	-$1.41M	0.06%	242
2019 Q1	$72.6M	Sell	1,346,155 -1,762,801	-57%	-$109M	0.1%	200
2018 Q4	$204K	Buy	3,108,956 +399,487	+15%	+$29.8M	0.19%	83
2018 Q3	$213M	Buy	2,709,469 +1,504,632	+125%	+$108M	0.28%	88
2018 Q2	$77.5M	Sell	1,204,837 -272,734	-18%	-$18M	0.11%	196
2018 Q1	$91.9M	Buy	1,477,571 +117,722	+9%	+$8.45M	0.15%	155
2017 Q4	$98.6M	Sell	1,359,849 -4,420,635	-76%	-$321M	0.15%	161
2017 Q3	$470M	Sell	5,780,484 -549,089	-9%	-$43.4M	1.5%	11
2017 Q2	$509M	Sell	6,329,573 -1,703,514	-21%	-$135M	1.67%	11
2017 Q1	$631M	Buy	8,033,087 +353,621	+5%	+$28.2M	2.12%	8
2016 Q4	$606M	Buy	7,679,466 +2,146,347	+39%	+$174M	2.13%	5
2016 Q3	$492M	Sell	5,533,119 -218,802	-4%	-$20.7M	1.77%	5
2016 Q2	$551M	Buy	5,751,921 +388,608	+7%	+$38.7M	2%	5
2016 Q1	$556M	Buy	5,363,313 +280,803	+6%	+$27.3M	2.07%	5
2015 Q4	$497M	Buy	5,082,510 +188,523	+4%	+$18.5M	1.86%	4
2015 Q3	$472M	Sell	4,893,987 -596,264	-11%	-$62.7M	1.94%	3
2015 Q2	$576M	Buy	5,490,251 +43,422	+0.8%	+$4.44M	2.11%	3
2015 Q1	$562M	Sell	5,446,829 -49,205	-0.9%	-$4.98M	2.01%	3
2014 Q4	$529M	Buy	5,496,034 +123,435	+2%	+$10.9M	1.92%	3
2014 Q3	$428M	Buy	5,372,599 +1,084,893	+25%	+$85.5M	1.62%	5
2014 Q2	$323M	Sell	4,287,706 -225,294	-5%	-$17M	1.24%	8
2014 Q1	$338M	Buy	4,513,000 +90,638	+2%	+$6.4M	1.29%	8
2013 Q4	$317M	Buy	4,422,362 +109,793	+3%	+$7.05M	1.22%	8
2013 Q3	$245M	Buy	4,312,569 +34,940	+0.8%	+$2.08M	0.99%	17
2013 Q2	$245M	Buy	+4,277,629	New	+$248M	1.02%	14

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi Asset Management US's CVS Position: Q1 2021 in Review

Amundi Asset Management US increased its CVS Health (CVS) stake by 19% in Q1 2021, buying an estimated $36.2M and bringing the position to 3,159,089 shares worth $238M. The position accounts for 0.18% of the portfolio, ranked #123.

Amundi Asset Management US first reported a position in CVS in Q2 2013 and has held it in 32 quarters since. The position peaked at $631M in Q1 2017. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

Amundi Asset Management US held 3,159,089 shares of CVS Health worth $238M as of Q1 2021.
Amundi Asset Management US bought 497,151 CVS Health shares in Q1 2021, an estimated $36.2M.
CVS Health made up 0.18% of Amundi Asset Management US's portfolio in Q1 2021, its #123 holding.
Amundi Asset Management US first reported a position in CVS Health in Q2 2013 and has held it in 32 quarters since.
Amundi Asset Management US's CVS Health position peaked at $631M in Q1 2017.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.